🌟and that's a wrap!🌟
Today, we concluded two busy days for ACCESS-AD: our very first General Assembly, hosted in 🇳🇱 & bringing together colleagues from our 30 partner organisations.
👀 for a summary on the ACCESS-AD website - in the meantime, enjoy these team photos 💜
@ihieurope.bsky.social
Missed the ACCESS-AD launch and want to learn more?
Visit our website ▶️ www.access-ad.org
Check out our press release 📖https://www.eurekalert.org/news-releases/1112308
....And follow along for updates as our work moves forward!
Earlier this week, we launched ACCESS-AD 🚀
Today, we’re sharing a short video on how our @ihieurope.bsky.social project aims to support earlier diagnosis, safer treatment and better monitoring for #Alzheimer’s disease.
🎬 Watch the video to learn more and stay tuned!
👋 Say hello to new project @access-ad.bsky.social! They want to innovate how #AlzheimersDisease is diagnosed and treated in routine clinical practice - strengthening the care pathway with a vision of personalised care for every patient. #EUResearch #IHITransformingHealth #HealthInnovation
📣Follow @access-ad.bsky.social, a new @ihieurope.bsky.social project, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.
👉 Visit the project's website for more information: access-ad.org
Today is the launch of @access-ad.bsky.social, a five-year @ihieurope.bsky.social project advancing timely diagnosis and equitable treatment for Alzheimer’s disease across Europe.
We are delighted to be a partner in supporting this initiative together.
Learn more here: bit.ly/ACCESS-AD_la...
@access-ad.bsky.social builds on other @ihieurope.bsky.social initiatives including @ihi-prominent.bsky.social, @predictom.bsky.social, AD-RIDDLE and EPND, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.
Want to learn more about our vision, mission and consortium of public and private partners?
▶️ Visit our website: www.access-ad.org
A graphic with details about the ACCESS-AD project, detailing the number of partner organisations (30), countries involved (13) and project duration (5 years). A link to the website and contact email is also provided, and all funding organisations are acknowledged in the lower half of the graphic. The graphic features the ACCESS-AD logo, which depicts a brain composed of small, round dots in orange, and shades of teal. The tagline for the project is "Advancing Alzheimer's Disease Care".
👋Hello from ACCESS-AD!
We’re delighted to launch ACCESS-AD, a new @ihieurope.bsky.social project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across Europe 🇪🇺
Read our press release: bit.ly/ACCESS-AD_la...
